Whoever invested in Madrigal Pharma a year ago is probably celebrating his astronomicaly high profits. Despite a clear backwards movement since February, the stock is still noted at 113.14 USD and therefore almost eight times as high as it was 12 months ago. However, the time of big price jumps seems to be over now.
Where the price is going now only ... Mehr lesen…
Ein Beitrag von Gideon Tanner.



